By David Bautz, PhD NASDAQ:MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Additional Positive Data from Phase 1 MAD Study of DA-1726 in Obesity On April 22, 2025, MetaVia Inc. (NASDAQ:MTVA) announced additional positive topline results from the multiple ascending dose (MAD) Part 2 of the Phase 1 clinical trial of DA-1726 in obesity. … Read more
By David Bautz, PhD NASDAQ:MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Phase 1 MAD Data for DA-1726 On April 15, 2025, MetaVia Inc. (NASDAQ:MTVA) announced positive results from the Phase 1 Part 2 multiple ascending dose (MAD) trial of DA-1726 in obesity. The results showed that the cohort receiving 32 mg of … Read more
Concern about RTO planning is underscored by Amazon reportedly lacking enough space for its current in-office policy. Bloomberg said that “in recent interviews, employees complained of working from shared desks, crowded corporate canteens, and a lack of conference rooms for confidential calls or team meetings.” The publication also pointed to employee displeasure with having to … Read more